Vilin Bio Med Ltd (VILINBIO) is currently trading at 57.85 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Vilin Bio Med Limited is primarily engaged in manufacturing pharmaceutical products, specializing in both Beta-Lactam and Non-Beta-Lactam medicines. The company boasts a robust portfolio of over 1000 drug approvals across diabetic, neurological, and cardiovascular therapeutic areas. Vilin Bio Med has a state-of-the-art manufacturing facility and R&D foundation in Roorkee, enhancing its product innovation capabilities. The company's recent IPO in 2023 raised Rs 12 Crore, marking a significant step for its financial strategy and growth plans.

Over the past 52 weeks, Vilin Bio Med Ltd has traded between a low of ₹18.95 and a high of ₹60.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Vilin Bio Med Ltd has a market capitalization of approximately 91.12. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Vilin Bio Med Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 47.21 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 91.12 Cr, Vilin Bio Med Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Vilin Bio Med Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Vilin Bio Med Ltd is 47.21. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.